Clinical Trials Browser

Phase 2 × Suramin × Plasma cell × Clear all

NCT00002652 2013-02-04

Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell